drugset / Trial / NCT00649428
Safety and Efficacy Study of Isolagen TherapyTM in the Treatment of Nasolabial Fold Wrinkles
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety profile and the treatment effect of Isolagen TherapyTM compared with placebo when administered to bilateral nasolabial fold wrinkles.
Timeline
- Start
- 2006-10
- Primary completion
- 2008-07
- Completion
- 2009-05
Outcome
Met primary endpoint
registry Autologous Fibroblast vs Placebo; p = .00001; Cochran-Mantel-Haenszel NCT00649428 ↗
registry Autologous Fibroblasts vs Placebo; p <.00001; Cochran-Mantel-Haenszel NCT00649428 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | azficel-T | Cell therapy | — | Other |
Indications
No indication recorded.